In addition, knockdown of SPARC could inhibit AML cell proliferation through inducing cell cycle arrest at Phase G1/G0 and inhibit active p53-induced apoptosis through raising the levels of p53, caspase-9, caspase-3, and Fas [24, 31]. Here, SPARC is linked to acute myeloid leukemia.